-transparent.png){kind=logo}
OBJECTIVE CSF levels of inositol have been reported to be lower than normal in depressed subjects. The authors administered inositol to depressed patients in a double-blind, controlled trial. METHODS Under double-blind conditions, 12 g/day of inositol (N = 13) or placebo (N = 15) was administered to depressed patients for 4 weeks. RESULTS The overall improvement in scores on the Hamilton Depression Rating Scale was significantly greater for inositol than for placebo at week 4. No changes were noted in hematology or in kidney or liver function. CONCLUSIONS This may be the first use of the precursor strategy for a second messenger rather than a neurotransmitter in treating depression. Although inositol had a significant antidepressant effect in this study, replication is crucial.
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
July 1995,
The American journal of psychiatry,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
May 2014,
Journal of psychiatric research,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
June 2001,
Journal of clinical psychopharmacology,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
December 1985,
The Journal of clinical psychiatry,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
February 1995,
The American journal of psychiatry,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
February 2019,
Journal of affective disorders,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
February 1995,
Singapore medical journal,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
March 2005,
Prostaglandins, leukotrienes, and essential fatty acids,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
December 1996,
The American journal of psychiatry,
J Levine, and
Y Barak, and
M Gonzalves, and
H Szor, and
A Elizur, and
O Kofman, and
R H Belmaker
January 1988,
Neuropsychobiology,
